All posts

Follow Us

LinkedInInstagramX
Quarterly ResultsArchiveLast updated 31 October 20263 min read

Narayana (NH) Q2 FY27 Health Profit Lags Behind 73% Revenue Surge as UK Acquisition Weighs

Narayana Hrudayalaya's Q2 revenue jumped 73% on a UK acquisition, but profit grew only 16.5% as integration costs and a richer mix of complex procedures defined the quarter.

By Abhinav Singhvi, Founder & CEO Hexawealth · Created 31 October 2026

Narayana Hrudayalaya's Q2 FY27 saw a 73% revenue surge, largely from its UK acquisition. Profit grew at a slower 16.5%, with margins under pressure, while underlying India and Cayman businesses showed strong operational improvement.

Narayana Hrudayalaya’s latest quarter tells two stories. The headline is a massive revenue jump, powered by a recent acquisition. The underlying plot is about operational strength in its core hospitals, where higher-value treatments are boosting performance even as new costs settle in.

The numbers show the split. Consolidated revenue for Q2 FY27 reached ₹2,844 crore, a 73% leap from a year ago. Profit after tax grew 16.5% to ₹301 crore. The net profit margin contracted by 510 basis points to 10.6%, reflecting the dilution from the newly acquired, lower-margin UK business.

Revenue & profit

Revenue (₹ Cr)

Profit (₹ Cr)

Net Profit Margin (%)

MetricCurrentQ2 FY27PreviousQ1 FY27Same quarter LYQ2 FY26
Revenue (₹ Cr)
2,843.99YoY +73%
2,683.63
1,643.79
Profit (₹ Cr)
301.15YoY +17%
207.27
258.49
Net Profit Margin (%)
10.6YoY -32%
7.7
15.7

Why Revenue Outpaced Profit

The 73% year-on-year revenue surge was largely due to the acquisition of its UK business, as reported by CNBCTV18. This consolidation masks a healthier underlying trend. Excluding the UK, revenue grew 22.6%, driven by a 16.6% rise in the India business.

Higher patient volumes and a richer mix of complex procedures, like cardiac and oncology cases, fueled this growth. International patient revenue in India jumped 75.7%. This operational improvement lifted the India hospital EBITDA margin to 26.8% from 23.8% a year ago.

The Margin Squeeze and Its Timeline

The consolidated margin drop stems from the UK unit, which reported a net loss. Management, cited by Kotak Neo, attributes this to near-term separation-related costs and expects them to normalise over time. Higher depreciation and finance costs linked to the acquisition also slowed profit growth.

Meanwhile, the Cayman Islands business saw a sharp profitability improvement. Its insurance arm significantly narrowed losses, contributing to a strong sequential profit jump. The company’s net debt-to-equity ratio improved to 0.38 from 0.42 last quarter, providing room to fund its expansion.

Funding a Major Capacity Build-Out

The growth plan is ambitious. Narayana Health aims to increase its total bed capacity to over 7,800 through six projects in India, adding about 1,555 beds, as per a Medical Buyer report. The Banashankari hospital in Bengaluru started operations in late September. For FY27, the company has planned a total capital expenditure of ₹7,800 crore.

This expansion, funded by internal accruals and debt, is a multi-year bet on sustained demand. The key will be ramping up occupancy at these new facilities without sacrificing the improved case mix that is currently driving margins in the established Indian hospitals.

Key Points

  • Consolidated revenue grew 73% YoY to ₹2,844 crore, significantly boosted by the UK acquisition.
  • Underlying India business remained strong, with revenue up 16.6% and hospital EBITDA margin expanding 300 bps to 26.8%.
  • Net profit margin fell 510 bps YoY to 10.6%, pressured by integration costs and finance charges from the UK deal.
  • The Cayman operations showed sharp profit improvement, and net debt reduced sequentially.
  • A large bed expansion pipeline is underway, with a planned FY27 capex of ₹7,800 crore.

Hexa Perspective

This quarter highlights the transition from a pure organic growth story to a more complex, acquisition-integration phase. The core Indian hospital engine is firing, delivering better realizations per patient. The drag from the UK is acknowledged as temporary, but its turnaround is crucial for consolidated margins to recover meaningfully. Investors are weighing strong execution in existing assets against the capital and execution risk of a major expansion. The stock's valuation at a discount to the industry PE reflects this balance. The next few quarters will test management's ability to normalize UK costs while seamlessly integrating new capacity into its high-performing ecosystem.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Frequently asked questions

What were Narayana Hrudayalaya's Q2 FY27 results?
Narayana Hrudayalaya reported Q2 FY27 revenue of ₹2,844 crore, a 73% increase year-on-year. Profit after tax was ₹301 crore, up 16.5%. The net profit margin for the quarter was 10.6%. The revenue surge was largely due to the consolidation of its recently acquired UK business.
Did Narayana Hrudayalaya's profit rise or fall in Q2 FY27?
Narayana Hrudayalaya's profit rose in Q2 FY27. Profit after tax increased by 16.5% year-on-year to ₹301 crore. Sequentially, profit jumped 45.3% from the previous quarter, driven by strong performance in its India and Cayman Islands operations.
What is Narayana Hrudayalaya's revenue for Q2 FY27?
Narayana Hrudayalaya's consolidated operating revenue for Q2 FY27 was ₹2,844 crore. This represents a 73% growth compared to the same quarter last year, primarily due to the inclusion of its UK business following an acquisition.
Why did Narayana Hrudayalaya's net profit margin fall despite high revenue growth?
Narayana Hrudayalaya's net profit margin fell 510 basis points YoY to 10.6% because the high-margin growth in India was diluted by the consolidation of its newly acquired UK business. As reported by CNBCTV18, the UK unit incurred separation-related costs and reported a net loss, pulling down the consolidated profitability.
How is Narayana Hrudayalaya's India hospital business performing?
Narayana Hrudayalaya's India hospital business performed robustly in Q2 FY27. Revenue grew 16.6% year-on-year to ₹1,440 crore, driven by higher patient volumes and a richer mix of complex procedures. The hospital EBITDA margin expanded to 26.8%, up from 23.8% in Q2 FY26.
What are Narayana Hrudayalaya's expansion plans and capex?
Narayana Hrudayalaya plans to add around 1,555 beds through six projects, aiming for a total capacity of over 7,800 beds. For FY27, the company has planned a total capital expenditure of ₹7,800 crore, with ₹4,600 crore earmarked for growth and greenfield projects, as per an investor presentation.
What is the outlook for Narayana Hrudayalaya's UK business?
Management expects the near-term margin pressure in the UK business to normalize over time. The current costs are related to the post-acquisition separation process. The company is focused on shifting the payer mix and implementing cost efficiencies to improve the unit's profitability.
How did the Cayman Islands business perform in Q2 FY27?
The Cayman Islands business showed sharp profitability improvement. Operating revenue grew 28.2% year-on-year. More significantly, losses in the One Health insurance platform narrowed substantially, leading to a marked improvement in the overall profit for the Cayman operations.
What is Narayana Hrudayalaya's net debt position?
As of September 30, 2026, Narayana Hrudayalaya's net debt stood at ₹1,883 crore. The net debt-to-equity ratio improved to 0.38, down from 0.42 at the end of the previous quarter, indicating a strengthening balance sheet.
What was the stock's reaction to the Q2 FY27 results?
On the day of the results announcement, shares of Narayana Hrudayalaya ended at ₹1,700.00 on the BSE, down 0.83%. The market reaction was muted, possibly weighing the strong underlying operational performance against the near-term margin dilution from the UK acquisition.